RNA-seq data of 17 different types of cancer show that OPTN is overexpressed in pancreatic cancer, being the second most expressed autophagy receptor, after p62, in this type of cancer, and its expression correlated with a reduced survival of pancreatic ductal adenocarcinoma patients (134). This evidence concerns the gene OPTN and cancer.